Production (Stage)
OptimizeRx Corporation
OPRX
$12.19
-$0.45-3.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -32.15% | 51.65% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -32.15% | 51.65% | |||
| Cost of Revenue | -16.60% | 30.92% | |||
| Gross Profit | -39.41% | 63.78% | |||
| SG&A Expenses | -16.95% | 28.83% | |||
| Depreciation & Amortization | 0.00% | -0.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.18% | 28.15% | |||
| Operating Income | -158.17% | 438.68% | |||
| Income Before Tax | -248.73% | 122.21% | |||
| Income Tax Expenses | -147.46% | 379.80% | |||
| Earnings from Continuing Operations | -2,719.23% | 99.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,719.23% | 99.15% | |||
| EBIT | -158.17% | 438.68% | |||
| EBITDA | -122.84% | 3,990.91% | |||
| EPS Basic | -2,735.71% | 99.16% | |||
| Normalized Basic EPS | -248.33% | 189.59% | |||
| EPS Diluted | -2,757.14% | 99.16% | |||
| Normalized Diluted EPS | -248.33% | 189.59% | |||
| Average Basic Shares Outstanding | 0.28% | 0.52% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||